Omar Dewachi

Omar Dewachi

Auto-generated profile, based on publicly available information

Omar Dewachi

Conflict and Health Program, American University of Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in The Lancet
Verified
Journal Article
Closed access
ODOmar Dewachi
Omar Dewachi
MSMac Skelton
Mac Skelton
VNVinh-Kim Nguyen
Vinh-Kim Nguyen
FFFouad M Fouad
Fouad M Fouad
GSGhassan Abu Sitta
Ghassan Abu Sitta
RGRita Giacaman
Rita Giacaman

1 August 2018 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
AAAula Abbara
Aula Abbara
TRTimothy Rawson
Timothy Rawson
NKNabil Karah
Nabil Karah
WEWael Faroug Elamin
Wael Faroug Elamin
JHJames Hatcher
James Hatcher
ASAnnie Sparrow
Annie Sparrow
Current evidence describing antimicrobial resistance (AMR) in the context of the Syrian conflict is of poor quality and sparse in nature. This paper explores and reports the major drivers of AMR that were present in Syria pre-conflict and those that have emerged since its onset in March 2011. Drivers that existed before the conflict included a lack of enforcement of existing legislation to regulate over-the-counter antibiotics and notification of communicable diseases. This contributed to a number of drivers of AMR after the onset of conflict, and these were also compounded by the exodus of trained staff, the increase in overcrowding and unsanitary conditions, the increase in injuries, and economic sanctions limiting the availability of required laboratory medical materials and equipment. Addressing AMR in this context requires pragmatic, multifaceted action at the local, regional, and international levels to detect and manage potentially high rates of multidrug-resistant infections. Priorities are (1) the development of a competent surveillance system for hospital-acquired infections, (2) antimicrobial stewardship, and (3) the creation of cost-effective and implementable infection control policies. However, it is only by addressing the conflict and immediate cessation of the targeting of health facilities that the rehabilitation of the health system, which is key to addressing AMR in this context, can progress.

1 October 2018 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
AAAula Abbara
Aula Abbara
TRTimothy Rawson
Timothy Rawson
NKNabil Karah
Nabil Karah
WEWael Faroug Elamin
Wael Faroug Elamin
JHJames Hatcher
James Hatcher
ASAnnie Sparrow
Annie Sparrow
Antimicrobial resistance (AMR) in populations experiencing war has yet to be addressed, despite the abundance of contemporary conflicts and the protracted nature of twenty-first century wars, in combination with growing global concern over conflict-associated bacterial pathogens. The example of the Syrian conflict is used to explore the feasibility of using existing global policies on AMR in conditions of extreme conflict. The available literature on AMR and prescribing behaviour in Syria before and since the onset of the conflict in March 2011 was identified. Overall, there is a paucity of rigorous data before and since the onset of conflict in Syria to contextualize the burden of AMR. However, post onset of the conflict, an increasing number of studies conducted in neighbouring countries and Europe have reported AMR in Syrian refugees. High rates of multidrug resistance, particularly Gram-negative organisms, have been noted amongst Syrian refugees when compared with local populations. Conflict impedes many of the safeguards against AMR, creates new drivers, and exacerbates existing ones. Given the apparently high rates of AMR in Syria, in neighbouring countries hosting refugees, and in European countries providing asylum, this requires the World Health Organization and other global health institutions to address the causes, costs, and future considerations of conflict-related AMR as an issue of global governance.

3 November 2017 in Global Public Health
Verified
Journal Article
Closed access
ODOmar Dewachi
Omar Dewachi
ARAnthony Rizk
Anthony Rizk
NSNeil V. Singh
Neil V. Singh
The proliferation of conflicts across borders of Middle Eastern States has transformed the landscapes of health and healthcare across the region. In the case of Iraq, state healthcare has collapsed under the strain of protracted conflicts. Meanwhile, Lebanon’s post-war healthcare system is booming, and becoming more privatised. In this paper, we build on an ethnographic study on the movements and experiences of Iraqi patients in Lebanon to show how one of the consequences of war is the rise of alternative forms of healthcare–seeking practices and survival strategies – a therapeutic geography that is embedded in regional economies and geopolitical relations and reconfigurations. We argue for the need to reimagine the disconnectivity and connectivity of healthcare systems under war and conflict as grounded in the empirical realities and experiences of mobility in the Middle East.